Results 201 to 210 of about 34,931 (220)

Adjuvant Therapies and Patient and Tumor Characteristics Associated With Survival of Adult Patients With Adrenocortical Carcinoma

Journal of Clinical Endocrinology and Metabolism, 2014
Tobias Else, Shruti Jolly, Barbra S Miller   +2 more
exaly  

Prognostic Parameters of Metastatic Adrenocortical Carcinoma

Journal of Clinical Endocrinology and Metabolism, 2007
Jérôme Bertherat, Eric Baudin
exaly  

Adrenocortical carcinoma in the United States

Cancer, 2008
Karl Y Bilimoria, David J Bentrem, Electron Kebebew   +2 more
exaly  

Emerging drugs for adrenocortical carcinoma

Expert Opinion on Emerging Drugs, 2008
Alfredo Berruti, Giuseppe Reimondo, Mauro Papotti   +2 more
exaly  

Use of a topoisomerase I inhibitor (irinotecan, CPT-11) in metastatic adrenocortical carcinoma

Annals of Oncology, 2002
Alfred Penfornis, Martin Schlumberger
exaly  

Factors associated with survival in pediatric adrenocortical carcinoma: An analysis of the National Cancer Data Base (NCDB)

Journal of Pediatric Surgery, 2016
Brian C Gulack, Kristy L Rialon, Brian R Englum   +2 more
exaly  

Combination Chemotherapy in Advanced Adrenocortical Carcinoma

New England Journal of Medicine, 2012
Martin Fasnacht, Massimo Terzolo, Eric Baudin   +2 more
exaly  

Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options

Expert Review of Anticancer Therapy, 2018
Soraya Puglisi, Deborah Cosentini, Elisa Roca   +2 more
exaly  

PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma

OncoImmunology, 2019
Émilien Billon, Pascal Finetti, Alexandre Bertucci   +2 more
exaly  

THE IMPACT OF TUMOR STAGE ON PROGNOSIS IN CHILDREN WITH ADRENOCORTICAL CARCINOMA

Journal of Urology, 2005
Silvio Tucci, Rodolfo B Reis
exaly